Loading…

The Obesity Epidemic and Its Impact on Hypertension

Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associa...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of cardiology 2012-05, Vol.28 (3), p.326-333
Main Authors: Nguyen, Thang, MD, FRCPC, Lau, David C.W., MD, PhD, FRCPC
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3
cites cdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3
container_end_page 333
container_issue 3
container_start_page 326
container_title Canadian journal of cardiology
container_volume 28
creator Nguyen, Thang, MD, FRCPC
Lau, David C.W., MD, PhD, FRCPC
description Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.
doi_str_mv 10.1016/j.cjca.2012.01.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1015093744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0828282X12000025</els_id><sourcerecordid>1015093744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</originalsourceid><addsrcrecordid>eNp9kU1L5TAUhoOM6PXqH5jF0OVsWk_SpGlBBgZR7wXBhQruQm5yiun0y6QduP9-Uq7jwoXZnEWe94XzHEK-U8go0OKyyUxjdMaAsgxoBkCPyIpWtEglSPGNrKBkZcpK9nJKzkJoADiVsjghp4yJSnBerkj-9IrJww6Dm_bJzegsds4kurfJdgrJthu1mZKhTzb7Ef2EfXBDf06Oa90GvHifa_J8e_N0vUnvH-6217_vU8OlnNIil7WWGmvKoWICyh1ynUtuRc6tlXYnRF6XUMd_qrHSssi1BUsrMKIoEPM1-XnoHf3wNmOYVOeCwbbVPQ5zUFGCgCo28oiyA2r8EILHWo3eddrvI7RwhWrUIkstshRQFWXF0I_3_nnXof2I_LcTgasDgHHLvw69CsZhb9A6j2ZSdnBf9__6FDet653R7R_cY2iG2ffRn6IqxIx6XM61XIsyiI-J_B99Go34</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1015093744</pqid></control><display><type>article</type><title>The Obesity Epidemic and Its Impact on Hypertension</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Nguyen, Thang, MD, FRCPC ; Lau, David C.W., MD, PhD, FRCPC</creator><creatorcontrib>Nguyen, Thang, MD, FRCPC ; Lau, David C.W., MD, PhD, FRCPC</creatorcontrib><description>Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.</description><identifier>ISSN: 0828-282X</identifier><identifier>EISSN: 1916-7075</identifier><identifier>DOI: 10.1016/j.cjca.2012.01.001</identifier><identifier>PMID: 22595448</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age Distribution ; Aged ; Antihypertensive Agents - therapeutic use ; Attitude to Health ; Bariatric Surgery - methods ; Behavior Therapy - methods ; Body Mass Index ; Cardiovascular ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - therapy ; Child ; Combined Modality Therapy ; Comorbidity ; Female ; Humans ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - epidemiology ; Life Style ; Male ; Middle Aged ; Obesity - diagnosis ; Obesity - epidemiology ; Obesity - therapy ; Obesity, Morbid - diagnosis ; Obesity, Morbid - epidemiology ; Obesity, Morbid - therapy ; Prevalence ; Prognosis ; Risk Assessment ; Sex Distribution ; Treatment Outcome ; Young Adult</subject><ispartof>Canadian journal of cardiology, 2012-05, Vol.28 (3), p.326-333</ispartof><rights>Canadian Cardiovascular Society</rights><rights>2012 Canadian Cardiovascular Society</rights><rights>Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</citedby><cites>FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22595448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Thang, MD, FRCPC</creatorcontrib><creatorcontrib>Lau, David C.W., MD, PhD, FRCPC</creatorcontrib><title>The Obesity Epidemic and Its Impact on Hypertension</title><title>Canadian journal of cardiology</title><addtitle>Can J Cardiol</addtitle><description>Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Attitude to Health</subject><subject>Bariatric Surgery - methods</subject><subject>Behavior Therapy - methods</subject><subject>Body Mass Index</subject><subject>Cardiovascular</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - therapy</subject><subject>Child</subject><subject>Combined Modality Therapy</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Life Style</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Obesity - diagnosis</subject><subject>Obesity - epidemiology</subject><subject>Obesity - therapy</subject><subject>Obesity, Morbid - diagnosis</subject><subject>Obesity, Morbid - epidemiology</subject><subject>Obesity, Morbid - therapy</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Risk Assessment</subject><subject>Sex Distribution</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0828-282X</issn><issn>1916-7075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kU1L5TAUhoOM6PXqH5jF0OVsWk_SpGlBBgZR7wXBhQruQm5yiun0y6QduP9-Uq7jwoXZnEWe94XzHEK-U8go0OKyyUxjdMaAsgxoBkCPyIpWtEglSPGNrKBkZcpK9nJKzkJoADiVsjghp4yJSnBerkj-9IrJww6Dm_bJzegsds4kurfJdgrJthu1mZKhTzb7Ef2EfXBDf06Oa90GvHifa_J8e_N0vUnvH-6217_vU8OlnNIil7WWGmvKoWICyh1ynUtuRc6tlXYnRF6XUMd_qrHSssi1BUsrMKIoEPM1-XnoHf3wNmOYVOeCwbbVPQ5zUFGCgCo28oiyA2r8EILHWo3eddrvI7RwhWrUIkstshRQFWXF0I_3_nnXof2I_LcTgasDgHHLvw69CsZhb9A6j2ZSdnBf9__6FDet653R7R_cY2iG2ffRn6IqxIx6XM61XIsyiI-J_B99Go34</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>Nguyen, Thang, MD, FRCPC</creator><creator>Lau, David C.W., MD, PhD, FRCPC</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120501</creationdate><title>The Obesity Epidemic and Its Impact on Hypertension</title><author>Nguyen, Thang, MD, FRCPC ; Lau, David C.W., MD, PhD, FRCPC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Attitude to Health</topic><topic>Bariatric Surgery - methods</topic><topic>Behavior Therapy - methods</topic><topic>Body Mass Index</topic><topic>Cardiovascular</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - therapy</topic><topic>Child</topic><topic>Combined Modality Therapy</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Life Style</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Obesity - diagnosis</topic><topic>Obesity - epidemiology</topic><topic>Obesity - therapy</topic><topic>Obesity, Morbid - diagnosis</topic><topic>Obesity, Morbid - epidemiology</topic><topic>Obesity, Morbid - therapy</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Risk Assessment</topic><topic>Sex Distribution</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Thang, MD, FRCPC</creatorcontrib><creatorcontrib>Lau, David C.W., MD, PhD, FRCPC</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Thang, MD, FRCPC</au><au>Lau, David C.W., MD, PhD, FRCPC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Obesity Epidemic and Its Impact on Hypertension</atitle><jtitle>Canadian journal of cardiology</jtitle><addtitle>Can J Cardiol</addtitle><date>2012-05-01</date><risdate>2012</risdate><volume>28</volume><issue>3</issue><spage>326</spage><epage>333</epage><pages>326-333</pages><issn>0828-282X</issn><eissn>1916-7075</eissn><abstract>Abstract Global obesity rates have increased steadily in both developed and emerging countries over the past several decades with little signs of slowing down. Over 1.5 billion people worldwide are overweight or obese and over 40 million children under the age of 5 are overweight. Obesity is associated with increased morbidity, disability, and premature mortality from cardiovascular disease, diabetes, cancers, and musculoskeletal disorders. The personal and societal health and economic burden of this preventable disease pose a serious threat to our societies. Obesity is a major risk factor for hypertension and cardiovascular disease. Weight loss, through health behaviour modification and dietary sodium restriction, is the cornerstone in the treatment of obesity-related hypertension. Pharmacotherapy and bariatric surgery for obesity are adjunctive measures when health behaviour interventions fail to achieve the body weight and health targets. Successful management of overweight and obese persons requires a comprehensive, multifaceted framework that integrates population health, public health, and medical health models to dismantle the proximal and distal drivers of the obesogenic environment in which we live. Prevention of obesity is no longer a lofty but rather necessary goal that urgently calls for action from governments at all levels, in conjunction with all public and private sector stakeholders, in order to combat a serious and growing public health concern.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>22595448</pmid><doi>10.1016/j.cjca.2012.01.001</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0828-282X
ispartof Canadian journal of cardiology, 2012-05, Vol.28 (3), p.326-333
issn 0828-282X
1916-7075
language eng
recordid cdi_proquest_miscellaneous_1015093744
source ScienceDirect Freedom Collection 2022-2024
subjects Adolescent
Adult
Age Distribution
Aged
Antihypertensive Agents - therapeutic use
Attitude to Health
Bariatric Surgery - methods
Behavior Therapy - methods
Body Mass Index
Cardiovascular
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - therapy
Child
Combined Modality Therapy
Comorbidity
Female
Humans
Hypertension - diagnosis
Hypertension - drug therapy
Hypertension - epidemiology
Life Style
Male
Middle Aged
Obesity - diagnosis
Obesity - epidemiology
Obesity - therapy
Obesity, Morbid - diagnosis
Obesity, Morbid - epidemiology
Obesity, Morbid - therapy
Prevalence
Prognosis
Risk Assessment
Sex Distribution
Treatment Outcome
Young Adult
title The Obesity Epidemic and Its Impact on Hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A26%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Obesity%20Epidemic%20and%20Its%20Impact%20on%20Hypertension&rft.jtitle=Canadian%20journal%20of%20cardiology&rft.au=Nguyen,%20Thang,%20MD,%20FRCPC&rft.date=2012-05-01&rft.volume=28&rft.issue=3&rft.spage=326&rft.epage=333&rft.pages=326-333&rft.issn=0828-282X&rft.eissn=1916-7075&rft_id=info:doi/10.1016/j.cjca.2012.01.001&rft_dat=%3Cproquest_cross%3E1015093744%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-637fa7aef14092508be4a374d534dd7db553f80ff141ae9a763ad0d190c566ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1015093744&rft_id=info:pmid/22595448&rfr_iscdi=true